Search

Displaying results 181 - 190 of 81106 in total
  1. Drug

    Chloramphenicol

    go.drugbank.com/drugs/DB00446
    ApprovedInvestigationalVet approvedWithdrawn

    It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. … (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) The FDA has withdrawn all oral drug products containing chloramphenicol, due to the high risk of fatal aplastic anemia associated with this

    Mixtures: CORTIFENOL H POMADA OFTALMICA 4 G, ยาฉีดมาโนซีติน 250 มก.Products: SENTOKLORIN SUPOZİTUAR 250 MG, 100 ADET, ARMISETIN 5 ML 125 MG 100 ML SURUP
  2. Drug

    Sodium chloride

    go.drugbank.com/drugs/DB09153
    ApprovedInvestigationalVet approved

    It is listed on the World Health Organization Model List of Essential Medicines.

    Mixtures: CLORURO DE POTASIO 20 MEQ EN SODIO CLORURO 0.9 % POR 100 ML, CLORURO DE POTASIO40 MEQ EN SODIO CLORURO0.9% X 100 MLProducts: SERUM SALE 2000 MG/10 ML ENJEKSİYONLUK ÇÖZELTİ, 100 AMPUL, SERUM SALE 2000 MG/10 ML ENJEKSİYONLUK ÇÖZELTİ, 10 AMPUL
  3. Drug

    Ketoconazole

    go.drugbank.com/drugs/DB01026
    ApprovedInvestigational

    Ketoconazole and its predecessor [clotrimazole] continue to be used in topical formulations. … [A188054,A188057] These effects combined with waning efficacy led to its eventual replacement by triazole agents, [fluconazole], [itraconazole], [voriconazole], and [posaconazole].

    Mixtures: CLINDAMICINA/KETOCONAZOL 100 MG/400MGInternational brands: Orifungal M
  4. Drug

    Clarithromycin

    go.drugbank.com/drugs/DB01211
    ApprovedInvestigational

    Clarithromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.

    Mixtures: TRIO 1000 MG + 500 MG + 30 MG TEDAVİ PAKETİ, 6X7 ADET, TRIO 1000 MG + 500 MG + 30 MG TEDAVİ PAKETİ, 6X14 ADETProducts: CLARITROMICINA EG, LAGUR TABLETAS DE LIBERACION PROGRAMADA 500 MG
  5. Drug

    Mycophenolic acid

    go.drugbank.com/drugs/DB01024
    ApprovedInvestigational

    [A249175] This regimen can be used in place of the older anti-proliferative [azathioprine] due to its stronger immunosuppressive potency. … [L42165] It was derived from _Penicillium stoloniferum_, and has also shown antibacterial, antifungal and antiviral properties.[A249170].

    Synonyms: (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acidProducts: CELLCEPT 250 MG KAPSÜL, 100 ADET, INMUKEM® 200 MG / ML
  6. Drug

    Darbepoetin alfa

    go.drugbank.com/drugs/DB00012
    ApprovedInvestigational

    Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

    Products: ARANESP 100 UG, ARANESP 100 MIKROGRAMM FS
  7. Drug

    Nifedipine

    go.drugbank.com/drugs/DB01115
    ApprovedInvestigational

    Nifedipine, or BAY a 1040, is a first generation dihydropyridine L-type calcium channel blocker, similar to [nicardipine].

    Mixtures: PLENACOR LPProducts: DEPIN-E RETARD TABLETS 20 mg, NIFEDIPIN T 20 STADA RETARD TABLET 20 mg
  8. Drug

    Ipratropium

    go.drugbank.com/drugs/DB00332
    ApprovedInvestigational

    [A176939] It is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption.

    Mixtures: İPRAVENT 20 MCG/100 MCG AEROSOL İNHALASYONU, SÜSPANSİYON (200 DOZ), SALBUTAMOLO E IPRATROPIO BROMURO EGSynonyms: bromuro de ipratropio
  9. Drug

    Tuparstobart

    go.drugbank.com/drugs/DB19118
    Investigational

    Tuparstobart is under investigation in clinical trial NCT05287113 (Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-line Treatment in Participants With Pd-l1-positive (CPS

    Synonyms: gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV1-46*02 (80.4%)-(IGHD) -IGHJ4*01 (100%), CDR-IMGT[8.8.14] (26-33.51-58.97-110)) (1-121)-Homo sapiens IGHG1*03, G1m3, nG1m1, G1v29 CH2 A84.4 (CH1, R120 (218) (122-219), hinge 1-15 (220-234), CH2 N8
  10. Drug

    Rifamycin

    go.drugbank.com/drugs/DB11753
    ApprovedInvestigationalWithdrawn

    Falk Pharma Gmbh and it was granted a waiver for the tested conditions.[L4801] … further developed by Cosmo Technologies Ltd and approved in November 16, 2018 by the FDA as a prescription drug after being granted the designation of Qualified Infectious Disease Product which allowed it

    Mixtures: RIFOCIN 250 MG+10 MG/3 ML IM ENJEKSİYON İÇİN ÇÖZELTİ İÇEREN AMPUL, 100 ADET, RİF 250 MG/3 ML IM ENJEKSİYONLUK ÇÖZELTİ (100 AMPUL)Products: RIFAL IM 250 MG AMPUL, 100 ADET, RIFAL IM 125 MG AMPUL, 100 ADET